BioNTech SE ADR buy stepdown
Start price
31.12.20
/
100%
€70.99
Target price
31.12.21
€170.00
Performance (%)
216.81%
End price
01.01.22
€224.90
Summary
This prediction ended on 01.01.22 with a price of €224.90. The BUY prediction by stepdown for BioNTech SE ADR saw massive gains of 216.81%. stepdown has 100% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
According to stepdown what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
EBIT growth > 30% per year expected
Rising EBIT margin expected
Very positive Cash Flow expected
Very valuable balance sheet
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Good culture
Strong uniques
Growths faster than the competition
Market Leader or Top 3
Could be worthwhile Investment >10% per year
Undervalued
Top Rating
Standard Investments for future growth
Very differentiated customer and product portfolio
Well known brand
Future proof or reliable business model
Revenue growth > 30% per year expected
Leading role in innovation
Small cyclical dependencies
Cons
Comments by stepdown for this prediction
In the thread Biontech SE diskutieren
Kursziel geändert auf 170,0
In the thread Trading Biontech SE
Die von stepdown gewählte maximale Laufzeit wurde überschritten